mapping notes,item_number,section,naaccr_variable_code,naaccr_variable_name,Cancer Modifier Mapping,Map Measurement? (assumes Value) ,Maps To,new_concept,Athena URL,Already Done/,naaccr_variable_domain,concept_class_id,naaccr_variable_standard_concept,naaccr_item_start_date,naaccr_item_end_date,naaccr_item_400_parent,naaccr_item_522_parent,naaccr_variable_date,naaccr_variable_parent,naaccr_value_code,naaccr_value_name,naaccr_variable_domain-2,concept_class_id-2,naaccr_value_standard_concept
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@1,Grade I,Meas Value,NAACCR Value,S
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@2,Grade II,Meas Value,NAACCR Value,S
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@3,Grade III,Meas Value,NAACCR Value,S
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@4,Grade IV,Meas Value,NAACCR Value,S
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@5,T-Cell,Meas Value,NAACCR Value,S
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@6,B-Cell,Meas Value,NAACCR Value,S
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@7, cell,Meas Value,NAACCR Value,S
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@8,NK (natural killer) cell,Meas Value,NAACCR Value,S
,440,Cancer Identification,440,Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,440@9,"Grade/differentiation unknown, not stated, or not applicable",Meas Value,NAACCR Value,S
,441,Cancer Identification,441,Grade Path Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,441@1,Recorded as Grade I or 1,Meas Value,NAACCR Value,S
,441,Cancer Identification,441,Grade Path Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,441@2,Recorded as Grade II or 2,Meas Value,NAACCR Value,S
,441,Cancer Identification,441,Grade Path Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,441@3,Recorded as Grade III or 3,Meas Value,NAACCR Value,S
,441,Cancer Identification,441,Grade Path Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,441@4,Recorded as Grade IV or 4,Meas Value,NAACCR Value,S
,449,Cancer Identification,449,Grade Path System,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,449@2,Two-Grade System,Meas Value,NAACCR Value,S
,449,Cancer Identification,449,Grade Path System,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,449@3,Three-Grade System,Meas Value,NAACCR Value,S
,449,Cancer Identification,449,Grade Path System,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,449@4,Four-Grade System,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1635581,,https://athena.ohdsi.org/search-terms/terms/1635581,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@030,Score of 3,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1634628,,https://athena.ohdsi.org/search-terms/terms/1634628,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@040,Score of 4,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1635808,,https://athena.ohdsi.org/search-terms/terms/1635808,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@050,Score of 5,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1634634,,https://athena.ohdsi.org/search-terms/terms/1634634,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@060,Score of 6,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1633603,,https://athena.ohdsi.org/search-terms/terms/1633603,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@070,Score of 7,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1635278,,https://athena.ohdsi.org/search-terms/terms/1635278,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@080,Score of 8,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1634189,,https://athena.ohdsi.org/search-terms/terms/1634189,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@090,Score of 9,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1634750,,https://athena.ohdsi.org/search-terms/terms/1634750,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@110,"Low Grade, Bloom-Richardson (BR) grade 1, score not given",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1635449,,https://athena.ohdsi.org/search-terms/terms/1635449,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@120,"Medium (Intermediate) Grade, BR grade 2, score not given",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,1634207,,https://athena.ohdsi.org/search-terms/terms/1634207,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@130,"High Grade, BR grade 3, score not given",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@988,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code 988 may result in an edit error.)",Meas Value,NAACCR Value,
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,breast@2861,Nottingham or Bloom-Richardson (BR) Score/Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@2861@999,Neither BR grade nor BR score given|Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,lacrimal_gland@2861,Mucoepidermoid Carcinoma - Grade,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@2861@010,Low grade,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,lacrimal_gland@2861,Mucoepidermoid Carcinoma - Grade,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@2861@020,High grade,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,lacrimal_gland@2861,Mucoepidermoid Carcinoma - Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@2861@987,Not applicable: Histology not mucoepidermoid carcinoma,Meas Value,NAACCR Value,
,2861,Stage/Prognostic Factors,lacrimal_gland@2861,Mucoepidermoid Carcinoma - Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@2861@988,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code 988 may result in an edit error.)",Meas Value,NAACCR Value,
,2861,Stage/Prognostic Factors,lacrimal_gland@2861,Mucoepidermoid Carcinoma - Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@2861@998,No pathologic examination of primary site,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,lacrimal_gland@2861,Mucoepidermoid Carcinoma - Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@2861@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@011,"Primary pattern 1, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@012,"Primary pattern 1, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@013,"Primary pattern 1, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@014,"Primary pattern 1, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@015,"Primary pattern 1, secondary pattern 5",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@019,"Primary pattern 1, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@021,"Primary pattern 2, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@022,"Primary pattern 2, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@023,"Primary pattern 2, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@024,"Primary pattern 2, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@025,"Primary pattern 2, secondary pattern 5",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@029,"Primary pattern 2, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@031,"Primary pattern 3, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@032,"Primary pattern 3, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@033,"Primary pattern 3, secondary pattern 3",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1633601,,https://athena.ohdsi.org/search-terms/terms/1633601,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@034,"Primary pattern 3, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@035,"Primary pattern 3, secondary pattern 5",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@039,"Primary pattern 3, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@041,"Primary pattern 4, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@042,"Primary pattern 4, secondary pattern 2",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1634055,,https://athena.ohdsi.org/search-terms/terms/1634055,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@043,"Primary pattern 4, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@044,"Primary pattern 4, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@045,"Primary pattern 4, secondary pattern 5",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@049,"Primary pattern 4, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1634055,,https://athena.ohdsi.org/search-terms/terms/1634055,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@051,"Primary pattern 5, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@052,"Primary pattern 5, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@053,"Primary pattern 5, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@054,"Primary pattern 5, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,1635621,,https://athena.ohdsi.org/search-terms/terms/1635621,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@055,"Primary pattern 5, secondary pattern 5",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@059,"Primary pattern 5, secondary pattern unknown",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@099,"Primary pattern unknown, secondary pattern unknown",Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@988,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code 988 may result in an edit error.)",Meas Value,NAACCR Value,
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@998,No needle core biopsy/TURP performed,Meas Value,NAACCR Value,S
,2861,Stage/Prognostic Factors,prostate@2861,Gleason's Primary Pattern and Secondary Pattern Values on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2861@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2862,Stage/Prognostic Factors,prostate@2862,Gleason's Score on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2862@988,"Not applicable: Information not collected for this case (If this information is required by your standard setter, use of code 988 may result in an edit error.)",Meas Value,NAACCR Value,
,2862,Stage/Prognostic Factors,prostate@2862,Gleason's Score on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2862@998,No needle core biopsy/TURP performed,Meas Value,NAACCR Value,S
,2862,Stage/Prognostic Factors,prostate@2862,Gleason's Score on Needle Core Biopsy/Transurethral Resection of Prostate (TURP),Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2862@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@011,"Primary pattern 1, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@012,"Primary pattern 1, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@013,"Primary pattern 1, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@014,"Primary pattern 1, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@015,"Primary pattern 1, secondary pattern 5",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@019,"Primary pattern 1, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@021,"Primary pattern 2, secondary pattern 1",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@022,"Primary pattern 2, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@023,"Primary pattern 2, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@024,"Primary pattern 2, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@025,"Primary pattern 2, secondary pattern 5",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@029,"Primary pattern 2, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@031,"Primary pattern 3, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@032,"Primary pattern 3, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@033,"Primary pattern 3, secondary pattern 3",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1633601,,https://athena.ohdsi.org/search-terms/terms/1633601,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@034,"Primary pattern 3, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@035,"Primary pattern 3, secondary pattern 5",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@039,"Primary pattern 3, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@041,"Primary pattern 4, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@042,"Primary pattern 4, secondary pattern 2",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1634055,,https://athena.ohdsi.org/search-terms/terms/1634055,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@043,"Primary pattern 4, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@044,"Primary pattern 4, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@045,"Primary pattern 4, secondary pattern 5",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@049,"Primary pattern 4, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@051,"Primary pattern 5, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@052,"Primary pattern 5, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@053,"Primary pattern 5, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@054,"Primary pattern 5, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1635621,,https://athena.ohdsi.org/search-terms/terms/1635621,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@055,"Primary pattern 5, secondary pattern 5",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@059,"Primary pattern 5, secondary pattern unknown",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@099,"Primary pattern unknown, secondary pattern unknown",Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@988,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code 988 may result in an edit error.)",Meas Value,NAACCR Value,
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@998,No prostatectomy/autopsy performed,Meas Value,NAACCR Value,S
,2863,Stage/Prognostic Factors,prostate@2863,Gleason's Primary Pattern and Secondary Pattern Values on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2863@999,No residual disease on prostatectomy/autopsy|Unknown or no information |Not documented in patient record,Meas Value,NAACCR Value,S
,2864,Stage/Prognostic Factors,prostate@2864,Gleason's Score on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2864@988,"Not applicable: Information not collected for this case (If this information is required by your standard setter, use of code 988 may result in an edit error.)",Meas Value,NAACCR Value,
,2864,Stage/Prognostic Factors,prostate@2864,Gleason's Score on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2864@998,No prostatectomy/autopsy performed,Meas Value,NAACCR Value,S
,2864,Stage/Prognostic Factors,prostate@2864,Gleason's Score on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2864@999,No Gleason's score documented on prostatectomy/autopsy|No residual disease on prostatectomy/autopsy|Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@010,For NON-MUCINOUS tumors:| Well differentiated| Grade 1/4,Meas Value,NAACCR Value,S
concept granularity lost,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@011,For MUCINOUS tumors:| Grade 1/2| Grade 1/3| Grade 1/4| Low grade| Well differentiated||Stated as Grade 1 with no information on the total number of codes in the grading system,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@020,For NON-MUCINOUS tumors:| Moderately differentiated| Grade 2/4,Meas Value,NAACCR Value,S
concept granularity lost,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@021,For MUCINOUS tumors:| Grade 2/2| Grade 2/3| Grade 2/4| Grade 3/3| Grade 3/4| High grade| Moderately differentiated| Poorly differentiated|| Stated as Grade 2 or Grade 3 with no information on the total number of codes in the grading system,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@030,For NON-MUCINOUS tumors:| Poorly differentiated| Grade 3/4,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@040,For NON-MUCINOUS tumors:| Undifferentiated| Grade 4/4,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@988,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code 988 may result in an edit error.)",Meas Value,NAACCR Value,
,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@998,No pathologic confirmation of primary site tumor,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,appendix@2865,Histopathologic Grading,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@2865@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2865,Stage/Prognostic Factors,prostate@2865,Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1633991,,https://athena.ohdsi.org/search-terms/terms/1633991,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2865@010,Tertiary pattern 1,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,prostate@2865,Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1634870,,https://athena.ohdsi.org/search-terms/terms/1634870,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2865@020,Tertiary pattern 2,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,prostate@2865,Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1633295,,https://athena.ohdsi.org/search-terms/terms/1633295,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2865@030,Tertiary pattern 3,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,prostate@2865,Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1633951,,https://athena.ohdsi.org/search-terms/terms/1633951,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2865@040,Tertiary pattern 4,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,prostate@2865,Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,1634454,,https://athena.ohdsi.org/search-terms/terms/1634454,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2865@050,Tertiary pattern 5,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,prostate@2865,Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2865@988,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code 988 may result in an edit error.)",Meas Value,NAACCR Value,
,2865,Stage/Prognostic Factors,prostate@2865,Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2865@998,No prostatectomy/autopsy performed,Meas Value,NAACCR Value,S
,2865,Stage/Prognostic Factors,prostate@2865,Gleason's Tertiary Pattern Value on Prostatectomy/Autopsy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2865@999,No Gleason's tertiary pattern documented on prostatectomy/autopsy|No residual disease on prostatectomy/autopsy|Unknown or no information |Not documented in patient record,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,bile_ducts_intrahepat@2880,Alpha Fetoprotein (AFP) Interpretation,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@2880@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
concept granularity lost,2880,Stage/Prognostic Factors,bladder@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@2880@010,Low grade urothelial carcinoma,Meas Value,NAACCR Value,S
concept granularity lost,2880,Stage/Prognostic Factors,bladder@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@2880@020,High grade urothelial carcinoma,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,bladder@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@2880@888,OBSOLETE DATA CONVERTED V0200 |See code 988||Not applicable for this site,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,bladder@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@2880@987,Not applicable: Not a urothelial morphology,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,bladder@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@2880@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,bladder@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@2880@998,No pathologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,bladder@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@2880@999,Unknown WHO/ISUP grade|Not documented in patient record,Meas Value,NAACCR Value,
concept granularity lost,2880,Stage/Prognostic Factors,brain@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@2880@010,Grade I,Meas Value,NAACCR Value,S
concept granularity lost,2880,Stage/Prognostic Factors,brain@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@2880@020,Grade II,Meas Value,NAACCR Value,S
concept granularity lost,2880,Stage/Prognostic Factors,brain@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@2880@030,Grade III,Meas Value,NAACCR Value,S
concept granularity lost,2880,Stage/Prognostic Factors,brain@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@2880@040,Grade IV,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,brain@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@2880@988,"Not applicable: Information not collected for this case|(If this item is required by your standard setter, use of code 988 will result in an edit error.)",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,brain@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@2880@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,brain@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@2880@999,Not documented in medical record|Unknown; WHO grade not stated,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,cns_other@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@2880@010,Grade I,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,cns_other@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@2880@020,Grade II,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,cns_other@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@2880@030,Grade III,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,cns_other@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@2880@040,Grade IV,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,cns_other@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@2880@988,"Not applicable: Information not collected for this case|(If this item is required by your standard setter, use of code 988 will result in an edit error.)",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,cns_other@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@2880@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,cns_other@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@2880@999,Not documented in medical record|Unknown; WHO grade not stated,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,endocrine_other@2880,OBSOLETE - WHO Grade Classification,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@2880@010,OBSOLETE DATA RETAINED V0200||Grade I,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,endocrine_other@2880,OBSOLETE - WHO Grade Classification,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@2880@020,OBSOLETE DATA RETAINED V0200||Grade II,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,endocrine_other@2880,OBSOLETE - WHO Grade Classification,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@2880@030,OBSOLETE DATA RETAINED V0200||Grade III,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,endocrine_other@2880,OBSOLETE - WHO Grade Classification,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@2880@040,OBSOLETE DATA RETAINED V0200||Grade IV,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,endocrine_other@2880,OBSOLETE - WHO Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@2880@988,Not applicable for this schema (CS Version 2),Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,endocrine_other@2880,OBSOLETE - WHO Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@2880@999,"OBSOLETE DATA RETAINED V0200||Clinically diagnosed/grade unknown|Does not apply|Not documented in medical record|Grade unknown, NOS",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@010,Specified as Grade 1 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@020,Specified as Grade 2 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@030,Specified as Grade 3 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@100,"Grade stated as low grade, NOS",Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@200,"Grade stated as high grade, NOS",Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@888,OBSOLETE DATA CONVERTED V0200|See code 988||Not applicable for this schema,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,heart_mediastinum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum@2880@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,intracranial_gland@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@2880@010,Grade I,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,intracranial_gland@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@2880@020,Grade II,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,intracranial_gland@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@2880@030,Grade III,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,intracranial_gland@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@2880@040,Grade IV,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,intracranial_gland@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@2880@988,"Not applicable: Information not collected for this case|(If this item is required by your standard setter, use of code 988 will result in an edit error.)",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,intracranial_gland@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@2880@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,intracranial_gland@2880,World Health Organization (WHO) Grade Classification,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@2880@999,Not documented in medical record|Unknown; WHO grade not stated,Meas Value,NAACCR Value,
concept granularity lost,2880,Stage/Prognostic Factors,kidney_renal_pelvis@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@2880@010,Low grade urothelial carcinoma,Meas Value,NAACCR Value,S
concept granularity lost,2880,Stage/Prognostic Factors,kidney_renal_pelvis@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@2880@020,High grade urothelial carcinoma,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,kidney_renal_pelvis@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@2880@888,OBSOLETE DATA CONVERTED V0200 |See code 988||Not applicable for this site,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,kidney_renal_pelvis@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@2880@987,Not applicable: Not a urothelial morphology,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,kidney_renal_pelvis@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@2880@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,kidney_renal_pelvis@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@2880@998,No pathologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,kidney_renal_pelvis@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@2880@999,Unknown WHO/ISUP grade|Not documented in patient record,Meas Value,NAACCR Value,
concept granularity lost,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@010,Specified as Grade 1 [of 3],Meas Value,NAACCR Value,S
concept granularity lost,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@020,Specified as Grade 2 [of 3],Meas Value,NAACCR Value,S
concept granularity lost,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@030,Specified as Grade 3 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@100,"Grade stated as low grade, NOS",Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@200,"Grade stated as high grade, NOS",Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@888,OBSOLETE DATA CONVERTED V0200|See code 988||Not applicable for this schema,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,peritoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,peritoneum@2880@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@010,Specified as Grade 1 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@020,Specified as Grade 2 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@030,Specified as Grade 3 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@100,"Grade stated as low grade, NOS",Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@200,"Grade stated as high grade, NOS",Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@888,OBSOLETE DATA CONVERTED V0200|See code 988||Not applicable for this schema,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,retroperitoneum@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@2880@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@010,Specified as Grade 1 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@020,Specified as Grade 2 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@030,Specified as Grade 3 [of 3],Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@100,"Grade stated as low grade, NOS",Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@200,"Grade stated as high grade, NOS",Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@888,OBSOLETE DATA CONVERTED V0200|See code 988||Not applicable for this schema,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,soft_tissue@2880,Grade for Sarcomas,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue@2880@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,urethra@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@2880@010,Low grade urothelial carcinoma,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,urethra@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@2880@020,High grade urothelial carcinoma,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,urethra@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@2880@888,OBSOLETE DATA CONVERTED V0200 |See code 988||Not applicable for this site,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,urethra@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@2880@987,Not applicable: Not a urothelial morphology,Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,urethra@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@2880@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2880,Stage/Prognostic Factors,urethra@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@2880@998,No pathologic examination of primary site,Meas Value,NAACCR Value,S
,2880,Stage/Prognostic Factors,urethra@2880,WHO/ISUP Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@2880@999,Unknown WHO/ISUP grade|Not documented in patient record,Meas Value,NAACCR Value,
concept granularity lost,2900,Stage/Prognostic Factors,melanoma_conjunctiva@2900,Grade - Melanoma Origin,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@2900@020,Grade 2 |Primary acquired melanosis (PAM) with cellular atypia (epithelial disease only)|Confined to epithelium,Meas Value,NAACCR Value,S
concept granularity lost,2900,Stage/Prognostic Factors,melanoma_conjunctiva@2900,Grade - Melanoma Origin,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@2900@030,Grade 3 |PAM with epithelial cellular atypia and invasive melanoma,Meas Value,NAACCR Value,S
concept granularity lost,2900,Stage/Prognostic Factors,melanoma_conjunctiva@2900,Grade - Melanoma Origin,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@2900@040,Grade 4 |De novo malignant melanoma,Meas Value,NAACCR Value,S
,2900,Stage/Prognostic Factors,melanoma_conjunctiva@2900,Grade - Melanoma Origin,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@2900@888,OBSOLETE DATA CONVERTED V0200|See code 988||Not applicable for this site,Meas Value,NAACCR Value,
,2900,Stage/Prognostic Factors,melanoma_conjunctiva@2900,Grade - Melanoma Origin,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@2900@988,"Not applicable: Information not collected for this site-specific factor|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of co",Meas Value,NAACCR Value,
,2900,Stage/Prognostic Factors,melanoma_conjunctiva@2900,Grade - Melanoma Origin,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@2900@998,No pathologic examination of primary site tumor,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,1635479,,https://athena.ohdsi.org/search-terms/terms/1635479,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@000,Tumor Regression Grade 0|Complete response: No viable cancer cells|No residual tumor,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,1635394,,https://athena.ohdsi.org/search-terms/terms/1635394,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@010,Tumor Regression Grade 1|Moderate response: Single cells or small groups of cancer cells,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,1634517,,https://athena.ohdsi.org/search-terms/terms/1634517,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@020,Tumor Regression Grade 2|Minimal response: Residual cancer outgrown by fibrosis,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,1634617,,https://athena.ohdsi.org/search-terms/terms/1634617,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@030,Tumor Regression Grade 3|Poor response: Minimal or no tumor kill; extensive residual cancer,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@888,OBSOLETE DATA CONVERTED V0200|See code 988||Not applicable for this site.,Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@990,"Response present, but degree of response not further described",Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@998,No preoperative treatment or no resection of primary site after preoperative treatment,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,colon@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon@2920@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@000,OBSOLETE DATA RETAINED V0200 |Test not done (test was not ordered and was not performed),Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@011,"OBSOLETE DATA RETAINED V0200||Primary pattern 1, secondary pattern 1",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@012,"OBSOLETE DATA RETAINED V0200||Primary pattern 1, secondary pattern 2",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@013,"OBSOLETE DATA RETAINED V0200||Primary pattern 1, secondary pattern 3",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@014,"OBSOLETE DATA RETAINED V0200||Primary pattern 1, secondary pattern 4",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@015,"OBSOLETE DATA RETAINED V0200||Primary pattern 1, secondary pattern 5",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635621,,https://athena.ohdsi.org/search-terms/terms/1635621,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@019,"OBSOLETE DATA RETAINED V0200||Primary pattern 1, secondary pattern 9",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@021,"OBSOLETE DATA RETAINED V0200||Primary pattern 2, secondary pattern 1",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@022,"OBSOLETE DATA RETAINED V0200||Primary pattern 2, secondary pattern 2",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@023,"OBSOLETE DATA RETAINED V0200||Primary pattern 2, secondary pattern 3",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@024,"OBSOLETE DATA RETAINED V0200||Primary pattern 2, secondary pattern 4",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@025,"OBSOLETE DATA RETAINED V0200||Primary pattern 2, secondary pattern 5",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@029,"OBSOLETE DATA RETAINED V0200||Primary pattern 2, secondary pattern unknown",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@031,"OBSOLETE DATA RETAINED V0200||Primary pattern 3, secondary pattern 1",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@032,"OBSOLETE DATA RETAINED V0200||Primary pattern 3, secondary pattern 2",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@033,"OBSOLETE DATA RETAINED V0200||Primary pattern 3, secondary pattern 3",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1633601,,https://athena.ohdsi.org/search-terms/terms/1633601,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@034,"OBSOLETE DATA RETAINED V0200||Primary pattern 3, secondary pattern 4",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@035,"OBSOLETE DATA RETAINED V0200||Primary pattern 3, secondary pattern 5",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@039,"OBSOLETE DATA RETAINED V0200||Primary pattern 3, secondary pattern unknown",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@041,"OBSOLETE DATA RETAINED V0200||Primary pattern 4, secondary pattern 1",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@042,"OBSOLETE DATA RETAINED V0200||Primary pattern 4, secondary pattern 2",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1634055,,https://athena.ohdsi.org/search-terms/terms/1634055,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@043,"OBSOLETE DATA RETAINED V0200||Primary pattern 4, secondary pattern 3",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@044,"OBSOLETE DATA RETAINED V0200||Primary pattern 4, secondary pattern 4",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@045,"OBSOLETE DATA RETAINED V0200||Primary pattern 4, secondary pattern 5",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@049,"OBSOLETE DATA RETAINED V0200||Primary pattern 4, secondary pattern unknown",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@051,"OBSOLETE DATA RETAINED V0200||Primary pattern 5, secondary pattern 1",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@052,"OBSOLETE DATA RETAINED V0200||Primary pattern 5, secondary pattern 2",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@053,"OBSOLETE DATA RETAINED V0200||Primary pattern 5, secondary pattern 3",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@054,"OBSOLETE DATA RETAINED V0200||Primary pattern 5, secondary pattern 4",Meas Value,NAACCR Value,
concept granularity lost,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,1635621,,https://athena.ohdsi.org/search-terms/terms/1635621,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@055,"OBSOLETE DATA RETAINED V0200||Primary pattern 5, secondary pattern 5",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@059,"OBSOLETE DATA RETAINED V0200||Primary pattern 5, secondary pattern unknown",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@099,"OBSOLETE DATA RETAINED V0200||Primary pattern unknown, secondary pattern unknown",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@988,Not applicable: Information not collected for this schema,Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,prostate@2920,OBSOLETE - Gleason's Primary Pattern and Secondary Pattern Value,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2920@999,OBSOLETE DATA RETAINED V0200||Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,1635479,,https://athena.ohdsi.org/search-terms/terms/1635479,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@000,Tumor Regression Grade 0|Complete response: No viable cancer cells|No residual tumor,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,1635394,,https://athena.ohdsi.org/search-terms/terms/1635394,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@010,Tumor Regression Grade 1|Moderate response: Single cells or small groups of cancer cells,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,1634517,,https://athena.ohdsi.org/search-terms/terms/1634517,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@020,Tumor Regression Grade 2|Minimal response: Residual cancer outgrown by fibrosis,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,1634617,,https://athena.ohdsi.org/search-terms/terms/1634617,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@030,Tumor Regression Grade 3|Poor response: Minimal or no tumor kill; extensive residual cancer,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@888,OBSOLETE DATA CONVERTED V0200|See code 988||Not applicable for this site.,Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@990,"Response present, but degree of response not further described",Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@998,No preoperative treatment or no resection of primary site after preoperative treatment,Meas Value,NAACCR Value,S
,2920,Stage/Prognostic Factors,rectum@2920,Tumor Regression Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,rectum@2920@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@010,Grade 1,Meas Value,NAACCR Value,S
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@020,Grade 2,Meas Value,NAACCR Value,S
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@030,Grade 3,Meas Value,NAACCR Value,S
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@040,Grade 4,Meas Value,NAACCR Value,S
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@888,OBSOLETE DATA CONVERTED V0200 |See code 988| |Not applicable for this schema,Meas Value,NAACCR Value,
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@987,Not applicable: Not a renal cell carcinoma morphology,Meas Value,NAACCR Value,
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@988,"Not applicable: Information not collected for this case|(May include cases converted from code 888 used in CSv1 for """"Not applicable"""" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may resul",Meas Value,NAACCR Value,
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@998,No histologic examination of primary site,Meas Value,NAACCR Value,S
,2930,Stage/Prognostic Factors,kidney_parenchyma@2930,Fuhrman Nuclear Grade,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@2930@999,Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
,2930,Stage/Prognostic Factors,prostate@2930,OBSOLETE - Gleason's Score,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2930@000,OBSOLETE DATA RETAINED V0200||Test not done (test was not ordered and was not performed),Meas Value,NAACCR Value,
,2930,Stage/Prognostic Factors,prostate@2930,OBSOLETE - Gleason's Score,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2930@002-010,"OBSOLETE DATA RETAINED V0200||Gleason's Score (See Notes 1, 2 and 3)",Meas Value,NAACCR Value,
,2930,Stage/Prognostic Factors,prostate@2930,OBSOLETE - Gleason's Score,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2930@988,Not applicable: Information not collected for this schema,Meas Value,NAACCR Value,
,2930,Stage/Prognostic Factors,prostate@2930,OBSOLETE - Gleason's Score,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@2930@999,OBSOLETE DATA RETAINED V0200| |Unknown or no information|Not documented in patient record,Meas Value,NAACCR Value,
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@11,"Primary pattern 1, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@12,"Primary pattern 1, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@13,"Primary pattern 1, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@14,"Primary pattern 1, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@15,"Primary pattern 1, secondary pattern 5",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@19,"Primary pattern 1, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@21,"Primary pattern 2, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@22,"Primary pattern 2, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@23,"Primary pattern 2, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@24,"Primary pattern 2, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634249,,https://athena.ohdsi.org/search-terms/terms/1634249,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@25,"Primary pattern 2, secondary pattern 5",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@29,"Primary pattern 2, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@31,"Primary pattern 3, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@32,"Primary pattern 3, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@33,"Primary pattern 3, secondary pattern 3",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634832,,https://athena.ohdsi.org/search-terms/terms/1634832,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@34,"Primary pattern 3, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1633509,,https://athena.ohdsi.org/search-terms/terms/1633509,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@35,"Primary pattern 3, secondary pattern 5",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@39,"Primary pattern 3, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@41,"Primary pattern 4, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@42,"Primary pattern 4, secondary pattern 2",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634699,,https://athena.ohdsi.org/search-terms/terms/1634699,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@43,"Primary pattern 4, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1633509,,https://athena.ohdsi.org/search-terms/terms/1633509,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@44,"Primary pattern 4, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634774,,https://athena.ohdsi.org/search-terms/terms/1634774,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@45,"Primary pattern 4, secondary pattern 5",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@49,"Primary pattern 4, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@51,"Primary pattern 5, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634249,,https://athena.ohdsi.org/search-terms/terms/1634249,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@52,"Primary pattern 5, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1633509,,https://athena.ohdsi.org/search-terms/terms/1633509,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@53,"Primary pattern 5, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1634774,,https://athena.ohdsi.org/search-terms/terms/1634774,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@54,"Primary pattern 5, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,1635025,,https://athena.ohdsi.org/search-terms/terms/1635025,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@55,"Primary pattern 5, secondary pattern 5",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@59,"Primary pattern 5, secondary pattern unknown",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@X6,"Primary pattern unknown, secondary pattern unknown",Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@X7,No needle core biopsy/TURP performed,Meas Value,NAACCR Value,S
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@X8,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code X8 may result in an edit error.)",Meas Value,NAACCR Value,
,3838,Stage/Prognostic Factors,3838,Gleason Patterns Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3838@X9,Not documented in medical record|Gleason Patterns Clinical not assessed or unknown if assessed,Meas Value,NAACCR Value,
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@11,"Primary pattern 1, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@12,"Primary pattern 1, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@13,"Primary pattern 1, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@14,"Primary pattern 1, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@15,"Primary pattern 1, secondary pattern 5",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@19,"Primary pattern 1, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@21,"Primary pattern 2, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@22,"Primary pattern 2, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@23,"Primary pattern 2, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@24,"Primary pattern 2, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@25,"Primary pattern 2, secondary pattern 5",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@29,"Primary pattern 2, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@31,"Primary pattern 3, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@32,"Primary pattern 3, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@33,"Primary pattern 3, secondary pattern 3",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1633601,,https://athena.ohdsi.org/search-terms/terms/1633601,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@34,"Primary pattern 3, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@35,"Primary pattern 3, secondary pattern 5",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@39,"Primary pattern 3, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@41,"Primary pattern 4, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@42,"Primary pattern 4, secondary pattern 2",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1634055,,https://athena.ohdsi.org/search-terms/terms/1634055,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@43,"Primary pattern 4, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@44,"Primary pattern 4, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@45,"Primary pattern 4, secondary pattern 5",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@49,"Primary pattern 4, secondary pattern unknown",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@51,"Primary pattern 5, secondary pattern 1",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@52,"Primary pattern 5, secondary pattern 2",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@53,"Primary pattern 5, secondary pattern 3",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@54,"Primary pattern 5, secondary pattern 4",Meas Value,NAACCR Value,S
concept granularity lost,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,1635621,,https://athena.ohdsi.org/search-terms/terms/1635621,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@55,"Primary pattern 5, secondary pattern 5",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@59,"Primary pattern 5, secondary pattern unknown",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@X6,"Primary pattern unknown, secondary pattern unknown",Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@X7,No prostatectomy/autopsy performed,Meas Value,NAACCR Value,S
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@X8,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code X8 may result in an edit error.)",Meas Value,NAACCR Value,
,3839,Stage/Prognostic Factors,3839,Gleason Patterns Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3839@X9,Not documented in medical record|Gleason Patterns Pathological not assessed or unknown if assessed,Meas Value,NAACCR Value,
concept granularity lost,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@02,Gleason score 2,Meas Value,NAACCR Value,S
concept granularity lost,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@03,Gleason score 3,Meas Value,NAACCR Value,S
concept granularity lost,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@04,Gleason score 4,Meas Value,NAACCR Value,S
concept granularity lost,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@05,Gleason score 5,Meas Value,NAACCR Value,S
concept granularity lost,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1634989,,https://athena.ohdsi.org/search-terms/terms/1634989,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@06,Gleason score 6,Meas Value,NAACCR Value,S
,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1634249,,https://athena.ohdsi.org/search-terms/terms/1634249,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@07,Gleason score 7,Meas Value,NAACCR Value,S
,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1633509,,https://athena.ohdsi.org/search-terms/terms/1633509,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@08,Gleason score 8,Meas Value,NAACCR Value,S
,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1634774,,https://athena.ohdsi.org/search-terms/terms/1634774,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@09,Gleason score 9,Meas Value,NAACCR Value,S
,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,1635025,,https://athena.ohdsi.org/search-terms/terms/1635025,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@10,Gleason score 10,Meas Value,NAACCR Value,S
,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@X7,No needle core biopsy/TURP performed,Meas Value,NAACCR Value,S
,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@X8,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code X8 may result in an edit error.)",Meas Value,NAACCR Value,
,3840,Stage/Prognostic Factors,3840,Gleason Score Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3840@X9,Not documented in medical record|Gleason Score Clinical not assessed or unknown if assessed,Meas Value,NAACCR Value,
concept granularity lost,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@02,Gleason score 2,Meas Value,NAACCR Value,S
concept granularity lost,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@03,Gleason score 3,Meas Value,NAACCR Value,S
concept granularity lost,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@04,Gleason score 4,Meas Value,NAACCR Value,S
concept granularity lost,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@05,Gleason score 5,Meas Value,NAACCR Value,S
concept granularity lost,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1635297,,https://athena.ohdsi.org/search-terms/terms/1635297,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@06,Gleason score 6,Meas Value,NAACCR Value,S
,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@07,Gleason score 7,Meas Value,NAACCR Value,S
,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1634821,,https://athena.ohdsi.org/search-terms/terms/1634821,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@08,Gleason score 8,Meas Value,NAACCR Value,S
,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1635817,,https://athena.ohdsi.org/search-terms/terms/1635817,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@09,Gleason score 9,Meas Value,NAACCR Value,S
,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,1635621,,https://athena.ohdsi.org/search-terms/terms/1635621,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@10,Gleason score 10,Meas Value,NAACCR Value,S
,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@X7,No prostatectomy done,Meas Value,NAACCR Value,S
,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@X8,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code X8 may result in an edit error.)",Meas Value,NAACCR Value,
,3841,Stage/Prognostic Factors,3841,Gleason Score Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3841@X9,Not documented in medical record|Gleason Score Pathological not assessed or unknown if assessed,Meas Value,NAACCR Value,
,3842,Stage/Prognostic Factors,3842,Gleason Tertiary Pattern,Cancer Modifier: Grade?,,1633991,,https://athena.ohdsi.org/search-terms/terms/1633991,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3842@10,Tertiary pattern 1,Meas Value,NAACCR Value,S
,3842,Stage/Prognostic Factors,3842,Gleason Tertiary Pattern,Cancer Modifier: Grade?,,1634870,,https://athena.ohdsi.org/search-terms/terms/1634870,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3842@20,Tertiary pattern 2,Meas Value,NAACCR Value,S
,3842,Stage/Prognostic Factors,3842,Gleason Tertiary Pattern,Cancer Modifier: Grade?,,1633295,,https://athena.ohdsi.org/search-terms/terms/1633295,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3842@30,Tertiary pattern 3,Meas Value,NAACCR Value,S
,3842,Stage/Prognostic Factors,3842,Gleason Tertiary Pattern,Cancer Modifier: Grade?,,1633951,,https://athena.ohdsi.org/search-terms/terms/1633951,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3842@40,Tertiary pattern 4,Meas Value,NAACCR Value,S
,3842,Stage/Prognostic Factors,3842,Gleason Tertiary Pattern,Cancer Modifier: Grade?,,1634454,,https://athena.ohdsi.org/search-terms/terms/1634454,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3842@50,Tertiary pattern 5,Meas Value,NAACCR Value,S
,3842,Stage/Prognostic Factors,3842,Gleason Tertiary Pattern,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3842@X7,No prostatectomy/autopsy performed,Meas Value,NAACCR Value,S
,3842,Stage/Prognostic Factors,3842,Gleason Tertiary Pattern,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3842@X8,"Not applicable: Information not collected for this case|(If this information is required by your standard setter, use of code X8 may result in an edit error.)",Meas Value,NAACCR Value,
,3842,Stage/Prognostic Factors,3842,Gleason Tertiary Pattern,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,3842@X9,Not documented in medical record|Gleason Tertiary Pattern not assessed or unknown if assessed,Meas Value,NAACCR Value,
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3843@H,HG: High grade (>20 mitosis per 50 HPF),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3843@L,LG: Low grade (20 mitoses per 50 HPF),Meas Value,NAACCR Value,S
the horrible 'or',3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3843@M,TP53 or CTNNB Mutation,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3843@1,G1: Well differentiated (low grade),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3843@2,G2: Moderately differentiated (low grade),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3843@3,G3: Poorly differentiated (high grade),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3843@4,G4: Undifferentiated (high grade),Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3843@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3843@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3843@H,HG: High-grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3843@L,LG: Low-grade,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3843@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3843@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3843@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3843@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3843@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3843@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3843@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3843@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3843@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3843@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3843@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3843@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3843@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634750,,https://athena.ohdsi.org/search-terms/terms/1634750,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@1,"G1: Low combined histologic grade (favorable), SBR score of 3-5 points",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635449,,https://athena.ohdsi.org/search-terms/terms/1635449,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@2,G2: Intermediate combined histologic grade (moderately favorable); SBR score of 6-7 points,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634207,,https://athena.ohdsi.org/search-terms/terms/1634207,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@3,G3: High combined histologic grade (unfavorable); SBR score of 8-9 points,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769257,,https://athena.ohdsi.org/search-terms/terms/36769257,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@H,Nuclear Grade III (High) (in situ only),Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768755,,https://athena.ohdsi.org/search-terms/terms/36768755,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@L,Nuclear Grade I (Low) (in situ only),Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769109,,https://athena.ohdsi.org/search-terms/terms/36769109,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3843@M,Nuclear Grade II (interMediate) (in situ only),Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3843@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3843@3,G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3843@H,High grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3843@L,Low grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769539,,https://athena.ohdsi.org/search-terms/terms/36769539,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3843@S,Sarcomatous overgrowth,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635317,,https://athena.ohdsi.org/search-terms/terms/1635317,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3843@1,G1|FIGO Grade 1|G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635826,,https://athena.ohdsi.org/search-terms/terms/1635826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3843@2,G2|FIGO Grade 2|G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633887,,https://athena.ohdsi.org/search-terms/terms/1633887,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3843@3,G3|FIGO Grade 3|G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635317,,https://athena.ohdsi.org/search-terms/terms/1635317,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3843@1,G1|FIGO Grade 1|G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635826,,https://athena.ohdsi.org/search-terms/terms/1635826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3843@2,G2|FIGO Grade 2|G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633887,,https://athena.ohdsi.org/search-terms/terms/1633887,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3843@3,G3|FIGO Grade 3|G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3843@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3843@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3843@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3843@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3843@H,High grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3843@L,Low grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3843@H,High: Over 5 mitoses per 5 square mm,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3843@L,Low: 5 or fewer mitoses per 5 square mm,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3843@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3843@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3843@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hemeretic@3843@8,Not applicable,Meas Value,NAACCR Value,
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3843@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3843@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3843@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3843@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@1,G1: Nucleoli absent or inconspicuous and basophilic at 400x magnification,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@2,"G2: Nucleoli conspicuous and eosinophilic at 400x magnification, visible but not prominent at 100x magnification",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@3,G3: Nucleoli conspicuous and eosinophilic at 100x magnification,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@4,G4: Marked nuclear pleomorphism and/or multinucleate giant cells and/or rhabdoid and/or sarcomatoid differentiation,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3843@H,HG: High-grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3843@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3843@2,G2: Moderately differentiated: includes adenoid cystic carcinoma without basaloid (solid) pattern,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3843@3,G3: Poorly differentiated: includes adenoid cystic carcinoma with basaloid (solid) pattern,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma@3843@8,Not applicable,Meas Value,NAACCR Value,
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_cll_sll@3843@8,Not applicable,Meas Value,NAACCR Value,
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3843@1,G1: 0-5 centroblasts per HPF,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3843@2,G2: 6-15 centroblasts per HPF,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3843@3,G3: > 15 centroblasts,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3843@4,G3A: >15 centroblasts per HPF and centrocytes present,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3843@5,G3B: > 15 centroblasts per HPF and solid sheets of centroblasts,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3843@9,"Grade cannot be assessed (GX); Unknown |Not a follicular histology (9690/3, 9691/3, 9695/3, 9698/3)",Meas Value,NAACCR Value,S
the horrible 'or',3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3843@L,Low grade: Grade 1-2,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3843@1,G1: Spindle cell melanoma (>90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3843@2,G2: Mixed cell melanoma (>10% epithelioid cells and <90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3843@3,G3: Epithelioid cell melanoma (>90% epithelioid cells),Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3843@1,G1: Spindle cell melanoma (>90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3843@2,G2: Mixed cell melanoma (>10% epithelioid cells and <90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3843@3,G3: Epithelioid cell melanoma (>90% epithelioid cells),Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mycosis_fungoides@3843@8,Not applicable,Meas Value,NAACCR Value,
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3843@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3843@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3843@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3843@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3843@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3843@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3843@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3843@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3843@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3843@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3843@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3843@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3843@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3843@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3843@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3843@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3843@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3843@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3843@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3843@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3843@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3843@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3843@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3843@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3843@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3843@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3843@H,High grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3843@L,Low grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3843@H,"HG: High grade: more pleomorphism, with a nuclear size variation greater than 4:1; prominent nuclear membrane irregularities; chromatin alterations, including hyperchromasia or margination of chromatin; and prominent nucleoli. High-grade tumors show seve",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3843@L,"LG: Low grade: round monomorphic nuclei with only mild to moderate nuclear size variation, indistinct nucleoli, and chromatin characteristics resembling those of normal parathyroid or of adenoma",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3843@3,G3: Poorly differentiated/high grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,plasma_cell_disorders@3843@8,Not applicable,Meas Value,NAACCR Value,
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,plasma_cell_myeloma@3843@8,Not applicable,Meas Value,NAACCR Value,
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_cutaneous_lymphoma_non_mf_ss@3843@8,Not applicable,Meas Value,NAACCR Value,
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3843@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3843@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3843@H,High grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3843@L,Low grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633550,,https://athena.ohdsi.org/search-terms/terms/1633550,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@1,Grade Group 1: Gleason score less than or equal to 6,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633826,,https://athena.ohdsi.org/search-terms/terms/1633826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@2,Grade Group 2: Gleason score 7|Gleason pattern 3+4,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634459,,https://athena.ohdsi.org/search-terms/terms/1634459,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@3,Grade Group 3: Gleason score 7|Gleason pattern 4+3,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635079,,https://athena.ohdsi.org/search-terms/terms/1635079,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@4,Grade Group 4: Gleason score 8,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635009,,https://athena.ohdsi.org/search-terms/terms/1635009,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@5,Grade Group 5: Gleason score 9 or 10,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634249,,https://athena.ohdsi.org/search-terms/terms/1634249,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3843@E,"Stated as """"Gleason score 7"""" with no patterns documented or |Any Gleason patterns combination equal to 7 not specified in 2 or 3",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@1,G1: Tumor with areas of retinoma [retinocytoma] (fleurettes or neuronal differentiation),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@2,G2: Tumor with many rosettes (Flexner-Wintersteiner or Homer Wright),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@3,G3: Tumor with occasional rosettes (Flexner-Wintersteiner or Homer Wright),Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@4,G4: Tumor with poorly differentiated cells without rosettes and/or with extensive areas (more than half of tumor) of anaplasia,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3843@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3843@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3843@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3843@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3843@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3843@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3843@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3843@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3843@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3843@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3843@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3843@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3843@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3843@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3843@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3843@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3843@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3843@H,HG: High-grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3843@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3843@H,HG: High-grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3843@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3843@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3843@A,Well differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3843@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3843@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3843@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3843@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3843@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3843@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3843,Stage/Prognostic Factors,3843,Grade Clinical,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3843@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3844@H,HG: High grade (>20 mitosis per 50 HPF),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3844@L,LG: Low grade (20 mitoses per 50 HPF),Meas Value,NAACCR Value,S
the horrible 'or',3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3844@M,TP53 or CTNNB Mutation,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3844@1,G1: Well differentiated (low grade),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3844@2,G2: Moderately differentiated (low grade),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3844@3,G3: Poorly differentiated (high grade),Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3844@4,G4: Undifferentiated (high grade),Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3844@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3844@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3844@H,HG: High-grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3844@L,LG: Low-grade,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3844@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3844@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3844@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3844@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3844@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3844@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3844@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3844@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3844@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3844@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3844@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3844@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3844@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@1,"G1: Low combined histologic grade (favorable), SBR score of 3-5 points",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@2,G2: Intermediate combined histologic grade (moderately favorable); SBR score of 6-7 points,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@3,G3: High combined histologic grade (unfavorable); SBR score of 8-9 points,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769257,,https://athena.ohdsi.org/search-terms/terms/36769257,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@H,Nuclear Grade III (High) (in situ only),Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768755,,https://athena.ohdsi.org/search-terms/terms/36768755,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@L,Nuclear Grade I (Low) (in situ only),Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769109,,https://athena.ohdsi.org/search-terms/terms/36769109,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3844@M,Nuclear Grade II (interMediate) (in situ only),Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3844@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3844@3,G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3844@H,High grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3844@L,Low grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769539,,https://athena.ohdsi.org/search-terms/terms/36769539,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3844@S,Sarcomatous overgrowth,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635317,,https://athena.ohdsi.org/search-terms/terms/1635317,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3844@1,G1|FIGO Grade 1|G1: Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635826,,https://athena.ohdsi.org/search-terms/terms/1635826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3844@2,G2|FIGO Grade 2|G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633887,,https://athena.ohdsi.org/search-terms/terms/1633887,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3844@3,G3|FIGO Grade 3|G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635317,,https://athena.ohdsi.org/search-terms/terms/1635317,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3844@1,G1|FIGO Grade 1|G1: Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635826,,https://athena.ohdsi.org/search-terms/terms/1635826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3844@2,G2|FIGO Grade 2|G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633887,,https://athena.ohdsi.org/search-terms/terms/1633887,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3844@3,G3|FIGO Grade 3|G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3844@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3844@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3844@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3844@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3844@H,High grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3844@L,Low grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3844@H,High: Over 5 mitoses per 5 square mm,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3844@L,Low: 5 or fewer mitoses per 5 square mm,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3844@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3844@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3844@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hemeretic@3844@8,Not applicable,Meas Value,NAACCR Value,
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3844@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3844@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3844@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3844@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@1,G1: Nucleoli absent or inconspicuous and basophilic at 400x magnification,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@2,"G2: Nucleoli conspicuous and eosinophilic at 400x magnification, visible but not prominent at 100x magnification",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@3,G3: Nucleoli conspicuous and eosinophilic at 100x magnification,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@4,G4: Marked nuclear pleomorphism and/or multinucleate giant cells and/or rhabdoid and/or sarcomatoid differentiation,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3844@H,HG: High-grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3844@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3844@2,G2: Moderately differentiated: includes adenoid cystic carcinoma without basaloid (solid) pattern,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3844@3,G3: Poorly differentiated: includes adenoid cystic carcinoma with basaloid (solid) pattern,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma@3844@8,Not applicable,Meas Value,NAACCR Value,
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_cll_sll@3844@8,Not applicable,Meas Value,NAACCR Value,
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3844@1,G1: 0-5 centroblasts per HPF,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3844@2,G2: 6-15 centroblasts per HPF,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3844@3,G3: > 15 centroblasts,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3844@4,G3A: >15 centroblasts per HPF and centrocytes present,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3844@5,G3B: > 15 centroblasts per HPF and solid sheets of centroblasts,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3844@9,"Grade cannot be assessed (GX); Unknown |Not a follicular histology (9690/3, 9691/3, 9695/3, 9698/3)",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3844@L,Low grade: Grade 1-2,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3844@1,G1: Spindle cell melanoma (>90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3844@2,G2: Mixed cell melanoma (>10% epithelioid cells and <90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3844@3,G3: Epithelioid cell melanoma (>90% epithelioid cells),Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3844@1,G1: Spindle cell melanoma (>90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3844@2,G2: Mixed cell melanoma (>10% epithelioid cells and <90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3844@3,G3: Epithelioid cell melanoma (>90% epithelioid cells),Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mycosis_fungoides@3844@8,Not applicable,Meas Value,NAACCR Value,
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3844@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3844@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3844@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3844@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3844@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3844@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3844@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3844@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3844@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3844@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3844@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3844@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3844@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3844@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3844@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3844@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3844@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3844@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3844@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3844@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3844@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3844@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3844@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3844@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3844@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3844@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3844@H,High grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3844@L,Low grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3844@H,"HG: High grade: more pleomorphism, with a nuclear size variation greater than 4:1; prominent nuclear membrane irregularities; chromatin alterations, including hyperchromasia or margination of chromatin; and prominent nucleoli. High-grade tumors show seve",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3844@L,"LG: Low grade: round monomorphic nuclei with only mild to moderate nuclear size variation, indistinct nucleoli, and chromatin characteristics resembling those of normal parathyroid or of adenoma",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3844@3,G3: Poorly differentiated/high grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,plasma_cell_disorders@3844@8,Not applicable,Meas Value,NAACCR Value,
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,plasma_cell_myeloma@3844@8,Not applicable,Meas Value,NAACCR Value,
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_cutaneous_lymphoma_non_mf_ss@3844@8,Not applicable,Meas Value,NAACCR Value,
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3844@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3844@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3844@H,High grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3844@L,Low grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633550,,https://athena.ohdsi.org/search-terms/terms/1633550,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@1,Grade Group 1: Gleason score less than or equal to 6,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633826,,https://athena.ohdsi.org/search-terms/terms/1633826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@2,Grade Group 2: Gleason score 7|Gleason pattern 3+4,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634459,,https://athena.ohdsi.org/search-terms/terms/1634459,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@3,Grade Group 3: Gleason score 7|Gleason pattern 4+3,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635079,,https://athena.ohdsi.org/search-terms/terms/1635079,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@4,Grade Group 4: Gleason score 8,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635009,,https://athena.ohdsi.org/search-terms/terms/1635009,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@5,Grade Group 5: Gleason score 9 or 10,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3844@E,"Stated as """"Gleason score 7"""" with no patterns documented or |Any Gleason patterns combination equal to 7 not specified in 2 or 3",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@1,G1: Tumor with areas of retinoma [retinocytoma] (fleurettes or neuronal differentiation),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@2,G2: Tumor with many rosettes (Flexner-Wintersteiner or Homer Wright),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@3,G3: Tumor with occasional rosettes (Flexner-Wintersteiner or Homer Wright),Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@4,G4: Tumor with poorly differentiated cells without rosettes and/or with extensive areas (more than half of tumor) of anaplasia,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3844@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3844@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3844@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3844@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3844@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3844@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3844@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3844@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3844@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3844@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3844@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3844@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3844@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3844@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3844@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3844@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3844@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3844@H,HG: High-grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3844@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3844@H,HG: High-grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3844@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3844@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3844@A,Well differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3844@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3844@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3844@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3844@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3844@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3844@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3844,Stage/Prognostic Factors,3844,Grade Pathological,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3844@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adnexa_uterine_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3845@H,HG: High grade (>20 mitosis per 50 HPF),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3845@L,LG: Low grade (20 mitoses per 50 HPF),Meas Value,NAACCR Value,S
the horrible 'or',3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,adrenal_gland@3845@M,TP53 or CTNNB Mutation,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ampulla_vater@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3845@1,G1: Well differentiated (low grade),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3845@2,G2: Moderately differentiated (low grade),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3845@3,G3: Poorly differentiated (high grade),Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3845@4,G4: Undifferentiated (high grade),Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3845@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,anus@3845@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,appendix@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_distal@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_intrahepat@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bile_ducts_perihilar@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,biliary_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3845@H,HG: High-grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bladder@3845@L,LG: Low-grade,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3845@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3845@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3845@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_appendicular_skeleton@3845@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3845@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3845@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3845@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_pelvis@3845@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3845@1,"G1: Well differentiated, low grade",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3845@2,"G2: Moderately differentiated, high grade",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3845@3,"G3: Poorly differentiated, high grade",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,bone_spine@3845@H,"Stated as """"high grade"""" only",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,brain@3845@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@1,"G1: Low combined histologic grade (favorable), SBR score of 3-5 points",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@2,G2: Intermediate combined histologic grade (moderately favorable); SBR score of 6-7 points,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@3,G3: High combined histologic grade (unfavorable); SBR score of 8-9 points,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769257,,https://athena.ohdsi.org/search-terms/terms/36769257,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@H,Nuclear Grade III (High) (in situ only),Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768755,,https://athena.ohdsi.org/search-terms/terms/36768755,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@L,Nuclear Grade I (Low) (in situ only),Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769109,,https://athena.ohdsi.org/search-terms/terms/36769109,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,breast@3845@M,Nuclear Grade II (interMediate) (in situ only),Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,buccal_mucosa@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervical_lymph_nodes_occult_head_neck@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cervix@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cns_other@3845@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,colon_rectum@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,conjunctiva@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3845@3,G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3845@H,High grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3845@L,Low grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769539,,https://athena.ohdsi.org/search-terms/terms/36769539,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_adenosarcoma@3845@S,Sarcomatous overgrowth,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635317,,https://athena.ohdsi.org/search-terms/terms/1635317,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3845@1,G1|FIGO Grade 1|G1: Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635826,,https://athena.ohdsi.org/search-terms/terms/1635826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3845@2,G2|FIGO Grade 2|G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633887,,https://athena.ohdsi.org/search-terms/terms/1633887,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3845@3,G3|FIGO Grade 3|G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_carcinoma@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635317,,https://athena.ohdsi.org/search-terms/terms/1635317,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3845@1,G1|FIGO Grade 1|G1: Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635826,,https://athena.ohdsi.org/search-terms/terms/1635826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3845@2,G2|FIGO Grade 2|G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633887,,https://athena.ohdsi.org/search-terms/terms/1633887,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3845@3,G3|FIGO Grade 3|G3: Poorly differentiated or undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,corpus_sarcoma@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cutaneous_carcinoma_head_neck@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,cystic_duct@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,digestive_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,endocrine_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3845@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_gejunction@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3845@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,esophagus_including_ge_junction_squamous@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,eye_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3845@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3845@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3845@H,High grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,fallopian_tube@3845@L,Low grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,floor_mouth@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gallbladder@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_female_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,genital_male_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3845@H,High: Over 5 mitoses per 5 square mm,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gist@3845@L,Low: 5 or fewer mitoses per 5 square mm,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,gum@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3845@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3845@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3845@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,heart_mediastinum_pleura@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hemeretic@3845@8,Not applicable,Meas Value,NAACCR Value,
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,hypopharynx@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ill_defined_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@1,WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@2,WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@3,"WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@4,"WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@H,"Stated as """"high grade"""" NOS",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,intracranial_gland@3845@L,"Stated as """"low grade"""" NOS",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3845@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3845@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3845@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kaposi_sarcoma@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@1,G1: Nucleoli absent or inconspicuous and basophilic at 400x magnification,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@2,"G2: Nucleoli conspicuous and eosinophilic at 400x magnification, visible but not prominent at 100x magnification",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@3,G3: Nucleoli conspicuous and eosinophilic at 100x magnification,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@4,G4: Marked nuclear pleomorphism and/or multinucleate giant cells and/or rhabdoid and/or sarcomatoid differentiation,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_parenchyma@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3845@H,HG: High-grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,kidney_renal_pelvis@3845@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3845@2,G2: Moderately differentiated: includes adenoid cystic carcinoma without basaloid (solid) pattern,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3845@3,G3: Poorly differentiated: includes adenoid cystic carcinoma with basaloid (solid) pattern,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_gland@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lacrimal_sac@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_glottic@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_other@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_subglottic@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,larynx_supraglottic@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lip@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,liver@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lung@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma@3845@8,Not applicable,Meas Value,NAACCR Value,
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_cll_sll@3845@8,Not applicable,Meas Value,NAACCR Value,
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3845@1,G1: 0-5 centroblasts per HPF,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3845@2,G2: 6-15 centroblasts per HPF,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3845@3,G3: > 15 centroblasts,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3845@4,G3A: >15 centroblasts per HPF and centrocytes present,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3845@5,G3B: > 15 centroblasts per HPF and solid sheets of centroblasts,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3845@9,"Grade cannot be assessed (GX); Unknown |Not a follicular histology (9690/3, 9691/3, 9695/3, 9698/3)",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,?,,?,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,lymphoma_ocular_adnexa@3845@L,Low grade: Grade 1-2,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,major_salivary_glands@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,maxillary_sinus@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3845@1,G1: Spindle cell melanoma (>90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3845@2,G2: Mixed cell melanoma (>10% epithelioid cells and <90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3845@3,G3: Epithelioid cell melanoma (>90% epithelioid cells),Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_choroid_ciliary_body@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_conjunctiva@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_head_neck@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3845@1,G1: Spindle cell melanoma (>90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3845@2,G2: Mixed cell melanoma (>10% epithelioid cells and <90% spindle cells),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3845@3,G3: Epithelioid cell melanoma (>90% epithelioid cells),Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_iris@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,melanoma_skin@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,merkel_cell_skin@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,middle_ear@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mouth_other@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,mycosis_fungoides@3845@8,Not applicable,Meas Value,NAACCR Value,
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasal_cavity_ethmoid_sinus@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,nasopharynx@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_adrenal_gland@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3845@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3845@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3845@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_ampulla@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3845@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3845@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3845@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_appendix@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3845@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3845@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3845@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_colon_rectum@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3845@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3845@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3845@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_duodenum@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3845@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3845@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3845@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_jejunum_ileum@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3845@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3845@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3845@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_pancreas@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3845@1,G1: Mitotic count (per 10 HPF) less than 2 AND | Ki-67 index (%) less than 3,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3845@2,G2: Mitotic count (per 10 HPF) equal 2-20 OR| Ki-67 index (%) equal 3-20,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3845@3,G3: Mitotic count (per 10 HPF) greater than 20 OR | Ki-67 index (%) greater than 20,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,net_stomach@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3845@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3845@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3845@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,orbital_sarcoma@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_hpv_mediated_p16_pos@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,oropharynx_p16_neg@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3845@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3845@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3845@H,High grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,ovary@3845@L,Low grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,palate_hard@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pancreas@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3845@H,"HG: High grade: more pleomorphism, with a nuclear size variation greater than 4:1; prominent nuclear membrane irregularities; chromatin alterations, including hyperchromasia or margination of chromatin; and prominent nucleoli. High-grade tumors show seve",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,parathyroid@3845@L,"LG: Low grade: round monomorphic nuclei with only mild to moderate nuclear size variation, indistinct nucleoli, and chromatin characteristics resembling those of normal parathyroid or of adenoma",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3845@3,G3: Poorly differentiated/high grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,penis@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pharynx_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,placenta@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,plasma_cell_disorders@3845@8,Not applicable,Meas Value,NAACCR Value,
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,plasma_cell_myeloma@3845@8,Not applicable,Meas Value,NAACCR Value,
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,pleural_mesothelioma@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_cutaneous_lymphoma_non_mf_ss@3845@8,Not applicable,Meas Value,NAACCR Value,
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3845@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3845@B,GB: Borderline Tumor,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3845@H,High grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,primary_peritoneal_carcinoma@3845@L,Low grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633550,,https://athena.ohdsi.org/search-terms/terms/1633550,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@1,Grade Group 1: Gleason score less than or equal to 6,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633826,,https://athena.ohdsi.org/search-terms/terms/1633826,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@2,Grade Group 2: Gleason score 7|Gleason pattern 3+4,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634459,,https://athena.ohdsi.org/search-terms/terms/1634459,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@3,Grade Group 3: Gleason score 7|Gleason pattern 4+3,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635079,,https://athena.ohdsi.org/search-terms/terms/1635079,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@4,Grade Group 4: Gleason score 8,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635009,,https://athena.ohdsi.org/search-terms/terms/1635009,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@5,Grade Group 5: Gleason score 9 or 10,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635467,,https://athena.ohdsi.org/search-terms/terms/1635467,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,prostate@3845@E,"Stated as """"Gleason score 7"""" with no patterns documented or |Any Gleason patterns combination equal to 7 not specified in 2 or 3",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,respiratory_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634371,,https://athena.ohdsi.org/search-terms/terms/1634371,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@1,G1: Tumor with areas of retinoma [retinocytoma] (fleurettes or neuronal differentiation),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634752,,https://athena.ohdsi.org/search-terms/terms/1634752,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@2,G2: Tumor with many rosettes (Flexner-Wintersteiner or Homer Wright),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1633749,,https://athena.ohdsi.org/search-terms/terms/1633749,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@3,G3: Tumor with occasional rosettes (Flexner-Wintersteiner or Homer Wright),Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635792,,https://athena.ohdsi.org/search-terms/terms/1635792,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@4,G4: Tumor with poorly differentiated cells without rosettes and/or with extensive areas (more than half of tumor) of anaplasia,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retinoblastoma@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3845@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3845@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3845@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,retroperitoneum@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,sinus_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_eyelid@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,skin_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3845@4,G4: Undifferentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,small_intestine@3845@9,Grade cannot be assessed (GX); Unknown |Not applicable,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3845@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3845@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3845@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_abdomen_thoracic@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3845@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3845@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3845@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_head_neck@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3845@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3845@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3845@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3845@1,"G1: Sum of differentiation score, mitotic count score and necrosis score equals 2 or 3",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3845@2,"G2: Sum of differentiation score, mitotic count score and necrosis score of 4 or 5",Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3845@3,"G3: Sum of differentiation score, mitotic count score and necrosis score of 6, 7, or 8",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,soft_tissue_trunk_extremities@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3845@3,"G3: Poorly differentiated, undifferentiated",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,stomach@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,testis@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thymus@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,thyroid_medullary@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,tongue_anterior@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,trachea@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3845@H,HG: High-grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra@3845@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1635587,,https://athena.ohdsi.org/search-terms/terms/1635587,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3845@H,HG: High-grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,1634085,,https://athena.ohdsi.org/search-terms/terms/1634085,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urethra_prostatic@3845@L,LG: Low-grade,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3845@9,Grade cannot be assessed; Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3845@A,Well differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3845@B,Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3845@C,Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769737,,https://athena.ohdsi.org/search-terms/terms/36769737,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,urinary_other@3845@D,"Undifferentiated, anaplastic",Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vagina@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36768162,,https://athena.ohdsi.org/search-terms/terms/36768162,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3845@1,G1: Well differentiated,Meas Value,NAACCR Value,S
concept granularity lost,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36770626,,https://athena.ohdsi.org/search-terms/terms/36770626,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3845@2,G2: Moderately differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,36769666,,https://athena.ohdsi.org/search-terms/terms/36769666,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3845@3,G3: Poorly differentiated,Meas Value,NAACCR Value,S
,3845,Stage/Prognostic Factors,3845,Grade Post Therapy,Cancer Modifier: Grade?,,0,,https://athena.ohdsi.org/search-terms/terms/0,,Measurement,NAACCR Variable,S,390:Date of Diagnosis,,400:Primary Site,522:Histology,,,vulva@3845@9,Grade cannot be assessed (GX); Unknown,Meas Value,NAACCR Value,S